Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Clinical Cardiology
|
August 8, 2021
Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi-country observational study
Eva Lesén, Christopher Hewitt, Evangelos Giannitsis, et al.
Frontiers in Cardiovascular Medicine
|
August 5, 2022
Understanding Study Drug Discontinuation Through EUCLID
E Hope Weissler, Hillary Mulder, Frank W Rockhold, et al.
Archives of Cardiovascular Diseases
|
May 26, 2019
Outcome associated with prescription of cardiac rehabilitation according to predicted risk after acute myocardial infarction: Insights from the FAST-MI registries
Etienne Puymirat, Marc Bonaca, Marie-Christine Iliou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2022
Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial
Brian I Rini, Javid J Moslehi, Marc Bonaca, et al.
Current Problems in Cardiology
|
May 16, 2024
Efficacy and Safety of P2Y<sub>12</sub> monotherapy vs standard DAPT in patients undergoing percutaneous coronary intervention: meta-analysis of randomized trials
Marta Casula, Gavino Casu, Giuseppe Talanas, et al.
Circulation
|
April 1, 2020
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
Nicholas A Marston, Yared Gurmu, Giorgio E M Melloni, et al.
JAMA
|
January 11, 2022
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial
Neil A Goldenberg, John M Kittelson, Thomas C Abshire, et al.
Diabetes, Obesity & Metabolism
|
April 3, 2020
Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE-TIMI 58 study
Avivit Cahn, Itamar Raz, Marc Bonaca, et al.
American Journal of Preventive Cardiology
|
July 3, 2026
American Heart Association lipoprotein(a) discovery project: A national initiative to advance awareness and lipoprotein(a) testing for patients with cardiovascular disease
Nishant P Shah, Zihang Gao, Shen Li, et al.
JAMA Internal Medicine
|
October 7, 2021
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
Alex C Spyropoulos, Mark Goldin, Dimitrios Giannis, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Clinical Cardiology
|
August 8, 2021
Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi-country observational study
Eva Lesén, Christopher Hewitt, Evangelos Giannitsis, et al.
Frontiers in Cardiovascular Medicine
|
August 5, 2022
Understanding Study Drug Discontinuation Through EUCLID
E Hope Weissler, Hillary Mulder, Frank W Rockhold, et al.
Archives of Cardiovascular Diseases
|
May 26, 2019
Outcome associated with prescription of cardiac rehabilitation according to predicted risk after acute myocardial infarction: Insights from the FAST-MI registries
Etienne Puymirat, Marc Bonaca, Marie-Christine Iliou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2022
Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial
Brian I Rini, Javid J Moslehi, Marc Bonaca, et al.
Current Problems in Cardiology
|
May 16, 2024
Efficacy and Safety of P2Y<sub>12</sub> monotherapy vs standard DAPT in patients undergoing percutaneous coronary intervention: meta-analysis of randomized trials
Marta Casula, Gavino Casu, Giuseppe Talanas, et al.
Circulation
|
April 1, 2020
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
Nicholas A Marston, Yared Gurmu, Giorgio E M Melloni, et al.
JAMA
|
January 11, 2022
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial
Neil A Goldenberg, John M Kittelson, Thomas C Abshire, et al.
Diabetes, Obesity & Metabolism
|
April 3, 2020
Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE-TIMI 58 study
Avivit Cahn, Itamar Raz, Marc Bonaca, et al.
American Journal of Preventive Cardiology
|
July 3, 2026
American Heart Association lipoprotein(a) discovery project: A national initiative to advance awareness and lipoprotein(a) testing for patients with cardiovascular disease
Nishant P Shah, Zihang Gao, Shen Li, et al.
JAMA Internal Medicine
|
October 7, 2021
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
Alex C Spyropoulos, Mark Goldin, Dimitrios Giannis, et al.
Page
of 4